131 related articles for article (PubMed ID: 16035947)
1. Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.
Jarasch N; Martin U; Kamphausen E; Zell R; Wutzler P; Henke A
Viral Immunol; 2005; 18(2):355-64. PubMed ID: 16035947
[TBL] [Abstract][Full Text] [Related]
2. Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3.
Henke A; Zell R; Martin U; Stelzner A
Virology; 2003 Oct; 315(2):335-44. PubMed ID: 14585336
[TBL] [Abstract][Full Text] [Related]
3. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
4. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.
Szalay G; Sauter M; Hald J; Weinzierl A; Kandolf R; Klingel K
Am J Pathol; 2006 Dec; 169(6):2085-93. PubMed ID: 17148671
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-gamma.
Henke A; Jarasch N; Martin U; Zell R; Wutzler P
Viral Immunol; 2008 Mar; 21(1):38-48. PubMed ID: 18355121
[TBL] [Abstract][Full Text] [Related]
6. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
[TBL] [Abstract][Full Text] [Related]
7. NK-derived IFN-γ/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis.
Liu L; Yue Y; Xiong S
J Mol Cell Cardiol; 2014 Nov; 76():15-25. PubMed ID: 25123338
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice.
Henke A; Chiang CS; Zell R; Stelzner A
Antiviral Res; 2004 Nov; 64(2):131-6. PubMed ID: 15498609
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.
Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D
PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410
[TBL] [Abstract][Full Text] [Related]
10. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
Moreira AL; Tsenova L; Murray PJ; Freeman S; Bergtold A; Chiriboga L; Kaplan G
Microb Pathog; 2000 Sep; 29(3):175-85. PubMed ID: 10968949
[TBL] [Abstract][Full Text] [Related]
11. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
[TBL] [Abstract][Full Text] [Related]
12. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene.
Gao JJ; Filla MB; Fultz MJ; Vogel SN; Russell SW; Murphy WJ
J Immunol; 1998 Nov; 161(9):4803-10. PubMed ID: 9794412
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
Zell R; Markgraf R; Schmidtke M; Görlach M; Stelzner A; Henke A; Sigusch HH; Glück B
Med Microbiol Immunol; 2004 May; 193(2-3):91-100. PubMed ID: 14513374
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.
Van Linthout S; Savvatis K; Miteva K; Peng J; Ringe J; Warstat K; Schmidt-Lucke C; Sittinger M; Schultheiss HP; Tschöpe C
Eur Heart J; 2011 Sep; 32(17):2168-78. PubMed ID: 21183501
[TBL] [Abstract][Full Text] [Related]
16. Exogenous and endogenous type I interferons inhibit interferon-gamma-induced nitric oxide production and nitric oxide synthase expression in murine peritoneal macrophages.
Deguchi M; Sakuta H; Uno K; Inaba K; Muramatsu S
J Interferon Cytokine Res; 1995 Nov; 15(11):977-84. PubMed ID: 8590310
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus B3-induced myocarditis.
Ursu ON; Sauter M; Ettischer N; Kandolf R; Klingel K
Cell Physiol Biochem; 2014; 33(1):52-66. PubMed ID: 24401606
[TBL] [Abstract][Full Text] [Related]
18. Effect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3.
Seko Y
Clin Sci (Lond); 2006 Mar; 110(3):379-86. PubMed ID: 16336207
[TBL] [Abstract][Full Text] [Related]
19. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
20. Expression of inducible nitric oxide synthase in experimental viral myocarditis.
Glück B; Merkle I; Dornberger G; Stelzner A
Herz; 2000 May; 25(3):255-60. PubMed ID: 10904848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
